Physicians
Industry Surveys
Breakthroughs Reports
Events
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
- Service Lines
Aetna backs off a colonoscopy change
New York Times, February 28, 2008
Aetna has announced that it had suspended a plan to stop paying for routine use of a powerful anesthetic in a procedure to screen for colon cancer. The drug, propofol, provides quick and reliable sedation for patients who are undergoing a colonoscopy. Critics had said that restricting use of propofol would discourage patients from undergoing a colonoscopy. The American Gastroenterological Association, a medical society representing the doctors who perform colonoscopies, had recommended that Aetna defer its plan and praised the company for the decision.
Most Viewed
Most Emailed
- 10 Major Changes to Health Reform in House's Reconciliation Bill
- Can 'Deadly Deliveries' Be a Wake-Up Call to Physicians, Hospitals?
- Match Day a Reminder of Primary Care's Struggles
- Cardiology Group Fights Medicare Pay Cuts by Offering Concierge Services
- Hospitals Make Employee Flu Vaccinations a Patient Safety Issue
- Physicians Generate $1.5M Annually for Their Hospitals, Says Survey
- 3 Lessons U.S. Healthcare Can Learn from France to Cut Infections
- Primary Care is Unappealing to Many Medical Students
- Hospital Monitors Infectious Diseases Using Real-Time Surveillance
- Where Have All the CEOs Gone?
